David C Litzinger

This inventor holds 17 USPTO granted patents and 15 published patent applications, plus 3 CIPO patents and 7 EPO patents. Top assignees: Ambrx, Inc., Amylin Pharmaceuticals, Inc., Astrazeneca Pharmaceuticals LP. Active years: 2009-2023.

USPTO Granted Patents = 17 (Patent Applications = 15)

% Patents Active = 41.2

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 5.0

ph-index = 8

Forward Citations = 194(Granted Patents)

Location History:

San Diego, CA (US) (2016 - 2022)
Poway, CA (US) (2009 - 2023)

Company Filing History:

Amylin Pharmaceuticals, Inc.

patents

2 out of 39

Astrazeneca Pharmaceuticals LP

patents

4. 1 out of 4

Aegerion Pharmaceuticals, Inc.

patents

5. 1 out of 3

Amryt Pharmaceuticals Inc.

where one patent can have more than one assignee

Years Active: 2009-2023

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11596648 - Emollient topical disinfectants (2023-03-07),

2. 11535659 - Engineered polypeptides having enhanced duration of action (2022-12-27),

3. 11446307 - Crystalline forms of a deoxycytidine kinase inhibitor and uses thereof (2022-09-20),

4. 9879063 - Engineered polypeptides having enhanced duration of action and reduced immunogenicity (2018-01-30),

5. 9593154 - Engineered polypeptides having enhanced duration of action (2017-03-14),

6. 9382304 - Engineered polypeptides having enhanced duration of action with reduced immunogenicity (2016-07-05),

7. 9260472 - Modified human four helical bundle polypeptides and their uses (2016-02-16),

8. 8907064 - Modified human four helical bundle polypeptides and their uses (2014-12-09),

9. 8906676 - Modified human four helical bundle polypeptides and their uses (2014-12-09),

10. 8778880 - Human growth hormone modified at position 35 (2014-07-15),

11. 8178494 - Modified human growth hormone formulations with an increased serum half-life (2012-05-15),

12. 8163695 - Formulations of human growth hormone comprising a non-naturally encoded amino acid (2012-04-24),

13. 8143216 - Modified human growth hormone (2012-03-27),

14. 8093356 - Pegylated human interferon polypeptides (2012-01-10),

15. 7939496 - Modified human growth horomone polypeptides and their uses (2011-05-10),

Title: David C Litzinger - Pioneering Inventor from Poway, CA

Introduction: David C Litzinger is a renowned inventor hailing from Poway, California. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology.

Latest Patents: David C Litzinger holds several patents in various technological domains, including software development, electronics, and telecommunications. His latest patents focus on cutting-edge advancements in artificial intelligence and renewable energy solutions.

Career Highlights: Throughout his illustrious career, David C Litzinger has worked with leading tech companies to bring his innovative ideas to life. He has a proven track record of developing groundbreaking technologies that have revolutionized the industry.

Collaborations: David C Litzinger has collaborated with top researchers, engineers, and scientists to push the boundaries of innovation. His collaborative efforts have resulted in the development of state-of-the-art products that have garnered international acclaim.

Conclusion: In conclusion, David C Litzinger's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the world of technology. His work continues to inspire the next generation of inventors and shape the future of technological advancements.